CSF1 and cancer: These results suggest that osteoblasts were induced to produce RANKL/M-CSF/OPG by stimulation with FGF1 or the MDA-MB-134-VI supernatant, whereas AZD4547 significantly inhibited this osteoblastic activation mediated by stimuli from cancer cells.